TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN. - Wikidata - wikimedia - TriplyDB

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

http://www.wikidata.org/entity/Q36350923

about

Vaccine adjuvants as potential cancer immunotherapeutics The TLR2 Binding Neisserial Porin PorB Enhances Antigen Presenting Cell Trafficking and Cross-presentation.Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line.Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine Mechanisms of transcriptional activation of the stimulator of interferon genes by transcription factors CREB and c-Myc.The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele.STING-mediated DNA sensing in cancer immunotherapy.Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins.cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response.Toll-like receptor 3 signal augments radiation-induced tumor growth retardation in a murine model.Local Immunotherapy of Cancer: Innovative Approaches to Harnessing Tumor-Specific Immune Responses.Synthesis of a hemin-containing copolymer as a novel immunostimulator that induces IFN-gamma production Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

P2860

Q26752522-A59320AE-37ED-4EED-A7C6-94B977EFB8D7 Q33673210-1DDC3A99-F280-461B-A549-98CDED735FBF Q35680341-74483CC7-13ED-426E-BD8E-F470768D0DBC Q36453386-CC9C83B7-8F50-45AB-A933-D50F6C6501E4 Q37061815-70829371-F4D1-444A-8537-B3AAE644C73B Q37709077-51167F2E-FAF2-4625-93A2-8E90934FC862 Q39121627-CE5F631D-8C5A-44FD-9C18-FBA96DF29FF5 Q39389951-5C63B1E1-28C2-422E-8C9A-5AFD910F4414 Q39450802-2334EE7D-AB2C-455E-A14B-A180292C5CE6 Q43170567-64012FD3-FDA2-4FEA-BF11-4A78B0B62B27 Q47132136-6EC2C9F9-D6FC-45A6-B889-4E44619C16DF Q49710218-CD855C0D-994B-4A46-90EA-3D50B40500DC Q52353493-FBC8F615-5BB6-4DD8-8F3E-7932EE71EB92 Q57583616-2580B58B-9E85-4CE1-BF40-87D3ABE6E029 Q58759112-77817964-E2CF-4888-94B3-F8AE6383862D

P2860

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

http://www.wikidata.org/entity/Q36350923

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

@ast

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

@en

type

label

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

@ast

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

@en

prefLabel

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

@ast

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

@en

P1433

Q36350923-E654FE49-502D-4E9E-94F6-10C8E2FE351A

P1476

Q36350923-129D8180-87B3-458D-8D3D-9106CD4BCC30

P2093

Q36350923-06FA4525-E78C-4CB8-A4D3-00D039D2DB67

Q36350923-1A422F5A-D28B-42B7-BD32-7D5197F7B73D

Q36350923-3D8D45A5-F8BE-449A-A39B-D3BE279972B7

Q36350923-55E8A791-1868-4D09-9DFB-50B0B4C4BE35

Q36350923-96351042-B914-4D33-90D1-A13C67FD502D

Q36350923-AF39666F-5CE3-4CDF-A37D-0FB99B55DA13

Q36350923-E374015C-C6AD-4606-BE70-6C13F15D264C

P2860

Q36350923-034856A6-F41F-482E-8CD2-752805211407

Q36350923-06CAEEB8-0B81-47D7-B2F6-27723E073864

Q36350923-0FD0B594-9CEE-4DF1-AC00-A0058DEC5EBD

Q36350923-125EE6AB-D78D-44BF-B008-B825D3CD9BF6

Q36350923-1D716AC1-1C71-4101-BA02-CC91222DC00B

Q36350923-20B87F18-DD9E-474B-BA63-902240BED7E9

Q36350923-253D6FF3-74C2-47A4-B909-36A17A219555

Q36350923-2901F6CD-3F4D-4E36-A600-9FEA9655F9B2

Q36350923-2AEEB264-1E45-430C-BBDF-797C76C31621

Q36350923-36CB37F6-C134-42D3-BCB7-B49902CDDEC1

P304

Q36350923-05CE1259-31DF-4609-86E5-DA96FCA214E2

P31

Q36350923-90E1A7FD-39E4-4B18-8594-0067018F2D2C

P356

Q36350923-A97F505A-6005-49FE-B761-DF94D8315015

P407

Q36350923-452E5FA5-8D30-4205-B4A2-0F7807C2B842

P433

Q36350923-1C17642E-4CA3-42B2-A74F-B2151ADE7B3E

P478

Q36350923-628803A7-C178-422C-8A53-FFE54A244F6C

P50

Q36350923-97217934-606B-4216-8EF8-B4C4A29B4F93

P577

Q36350923-11786B07-CA92-460D-BB7C-F4396A16A105

P5875

Q36350923-F068A19F-FAD4-45BB-8DC5-9EBBA9B18FFD

P698

Q36350923-8CD7E424-227B-4740-9883-5AC9BB57BAD2

P921

Q36350923-A6B272DA-8ACC-4DE1-AC62-F685C0BB2EE4

P932

Q36350923-F2A4767C-D9DE-494B-BF45-CEEDFB459CCF

P356

P1433

European Journal of Immunology

P1476

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.

@en

P2093

Burcu Temizoz

http://www.w3.org/2001/XMLSchema#string

Etsushi Kuroda

http://www.w3.org/2001/XMLSchema#string

Keiichi Ohata

http://www.w3.org/2001/XMLSchema#string

Koji Ozasa

http://www.w3.org/2001/XMLSchema#string

Kouji Kobiyama

http://www.w3.org/2001/XMLSchema#string

Nao Jounai

http://www.w3.org/2001/XMLSchema#string

Taiki Aoshi

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway

IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12

STING is a direct innate immune sensor of cyclic di-GMP

A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP

Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants

Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STING

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA

A unique role for IL-23 in promoting cellular immunity

Cytoplasmic DNA innate immune pathways

P304

1159-1169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJI.201445132

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269877368

http://www.w3.org/2001/XMLSchema#string

P698

25529558

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

4671267

http://www.w3.org/2001/XMLSchema#string